(Q54104102)

24 May 2018

title

Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension. (English)

1 reference

24 May 2018

0 references

Mastaï R

1

1 reference

24 May 2018

Rocheleau B

series ordinal

2

1 reference

24 May 2018

Huet PM

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 1989

1 reference

24 May 2018

published in

Hepatology

1 reference

24 May 2018

volume

9

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

265-268

1 reference

24 May 2018

Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

Effect of two models of portal hypertension on splanchnic organ blood flow in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

200 years of digitalis: the emerging central role of the sodium ion in the control of cardiac force

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090217

7 January 2021

Identifiers

DOI

10.1002/HEP.1840090217

1 reference

24 May 2018

1 reference

24 May 2018